Jose D. Herazo‐Maya

eNAMPT Is a Novel DAMP and Therapeutic Target in Human and Murine Pulmonary Fibrosis

The transcriptome of CD14+CD163-HLA-DRlow monocytes predicts mortality in Idiopathic Pulmonary Fibrosis

The transcriptome of CD14 ⁺ CD163 ⁻ HLA-DR ^low monocytes predicts mortality in idiopathic pulmonary fibrosis

Single-Cell Profiling Reveals Immune Aberrations in Progressive Idiopathic Pulmonary Fibrosis

A lung targeted miR-29 mimic as a therapy for pulmonary fibrosis

Blood Transcriptomics Predicts Progression of Pulmonary Fibrosis and Associated Natural Killer Cells

50-gene risk profiles in peripheral blood predict COVID-19 outcomes: A retrospective, multicenter cohort study

Increased monocyte count as a cellular biomarker for poor outcomes in fibrotic diseases: a retrospective, multicentre cohort study

Transcriptional regulatory model of fibrosis progression in the human lung

PD-1 up-regulation on CD4 ⁺ T cells promotes pulmonary fibrosis through STAT3-mediated IL-17A and TGF-β1 production

BAL Cell Gene Expression Is Indicative of Outcome and Airway Basal Cell Involvement in Idiopathic Pulmonary Fibrosis

Thyroid hormone inhibits lung fibrosis in mice by improving epithelial mitochondrial function

Validation of a 52-gene risk profile for outcome prediction in patients with idiopathic pulmonary fibrosis: an international, multicentre, cohort study

Identification and validation of differentially expressed transcripts by RNA-sequencing of formalin-fixed, paraffin-embedded (FFPE) lung tissue from patients with Idiopathic Pulmonary Fibrosis

Integrative phenotyping framework (iPF): integrative clustering of multiple omics data identifies novel lung disease subphenotypes

A functional genomic model for predicting prognosis in idiopathic pulmonary fibrosis

Peripheral Blood Mononuclear Cell Gene Expression Profiles Predict Poor Outcome in Idiopathic Pulmonary Fibrosis